2+ day, 30+ min ago  (1585+ words) Penn professor Kiran Musunuru is optimistic regulatory landscape can keep up with rapidly advancing genome editing technology. Few moments in the history of medicine have been as earth-shaking as what scientists achieved in Philadelphia last year. For the first time,…...

2+ day, 2+ hour ago  (244+ words) Tax compliance impacts manufacturing and IP strategy. For finance and accounting professionals, compliance has evolved far beyond traditional corporate income tax. Corporate tax considerations now encompass sales tax and multi-state complexity, which further scales into where many in the life…...

3+ day, 11+ hour ago  (366+ words) The merger between GHO Capital and CBC Group unlocks access to three continents and will capture 90% of the world's healthcare R&D investment. The strategic rationale is clear. European specialist healthcare investor GHO Capital gains immediate access to APAC markets…...

3+ day, 4+ hour ago  (276+ words) Proactive internal controls help firms scale confidently even if they are not planning an IPO. For many private companies, the question of when to implement internal controls and SOX compliance often arises only when an IPO looms on the horizon....

3+ day, 4+ hour ago  (554+ words) The partnership between Bristol Myers Squibb (BMS) and Anthropic will integrate Claude artificial intelligence (AI) across all major business functions at BMS. The platform will serve as a shared intelligence system for more than 30, 000 employees worldwide spanning research, clinical development,…...

4+ day, 8+ hour ago  (548+ words) Licensing and venture capital hold steady at $7. 5 billion, but early-stage companies face tightening capital amid selective deployment. The medtech sector has experienced a relatively stable period. This is underpinned by continued M&A activity and a late-stage venture funding environment…...

5+ day, 2+ hour ago  (368+ words) The deal will see Parabilis Medicines receive $50 million in upfront payments and a further $75 million investment in its next equity financing round. Parabilis is also eligible for development, regulatory and commercial milestones totaling up to approximately $2. 2 billion." "We have not…...

5+ day, 22+ hour ago  (521+ words) Dark Horse and Kun Tuo collaborate to streamline cell and gene therapy trials in China, enhancing global data reuse. Dark Horse Consulting will help Beijing clinical research organization (CRO) Kun Tuo Research and Development encourage sponsors to trial cell and…...

6+ day, 7+ hour ago  (815+ words) Eli Lilly grows through acquisitions and incretin drugs, with Q1 revenue hitting $19. 8 billion, focusing on obesity, oncology, and cell therapy. "2026 is off to a strong start," Eli Lilly CEO David Ricks said on a Q1 2026 earnings call. "During the quarter, we delivered…...

6+ day, 12+ hour ago  (475+ words) JPMorgan analysis shows biopharma licensing is "carrying the ecosystem" as early-stage funding crisis deepens. The biopharma industry entered 2026 with renewed momentum in dealmaking. But venture capital (VC) investors maintained their cautious stance on early-stage innovation. JPMorgan's Q1 2026 Biopharma Licensing and Venture Report…...